NO993943D0 - Kombinert tumorsuppressorgenterapi og kjemoterapi ved behandling av neoplasmer - Google Patents
Kombinert tumorsuppressorgenterapi og kjemoterapi ved behandling av neoplasmerInfo
- Publication number
- NO993943D0 NO993943D0 NO993943A NO993943A NO993943D0 NO 993943 D0 NO993943 D0 NO 993943D0 NO 993943 A NO993943 A NO 993943A NO 993943 A NO993943 A NO 993943A NO 993943 D0 NO993943 D0 NO 993943D0
- Authority
- NO
- Norway
- Prior art keywords
- tumor suppressor
- treatment
- neoplasms
- chemotherapy
- combined tumor
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Marine Sciences & Fisheries (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
- Electrotherapy Devices (AREA)
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US80168197A | 1997-02-18 | 1997-02-18 | |
US80175597A | 1997-02-18 | 1997-02-18 | |
US3806597P | 1997-02-18 | 1997-02-18 | |
US80128597A | 1997-02-18 | 1997-02-18 | |
US80176597A | 1997-02-18 | 1997-02-18 | |
US4783497P | 1997-05-28 | 1997-05-28 | |
PCT/US1998/003514 WO1998035554A2 (en) | 1997-02-18 | 1998-02-17 | Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms |
Publications (2)
Publication Number | Publication Date |
---|---|
NO993943D0 true NO993943D0 (no) | 1999-08-17 |
NO993943L NO993943L (no) | 1999-10-15 |
Family
ID=27556335
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO993943A NO993943L (no) | 1997-02-18 | 1999-08-17 | Kombinert tumorsuppressorgenterapi og kjemoterapi ved behandling av neoplasmer |
Country Status (19)
Country | Link |
---|---|
EP (1) | EP0969720B1 (no) |
JP (1) | JP2001511815A (no) |
KR (2) | KR100688409B1 (no) |
CN (1) | CN1248731C (no) |
AT (1) | ATE361668T1 (no) |
AU (1) | AU737621B2 (no) |
BR (1) | BR9807418A (no) |
CA (1) | CA2282683A1 (no) |
CZ (1) | CZ298488B6 (no) |
DE (1) | DE69837754T2 (no) |
ES (1) | ES2287974T3 (no) |
HK (1) | HK1026579A1 (no) |
HU (1) | HUP0004326A3 (no) |
IL (2) | IL131447A0 (no) |
NO (1) | NO993943L (no) |
NZ (1) | NZ337283A (no) |
PL (1) | PL193767B1 (no) |
SK (1) | SK285969B6 (no) |
WO (1) | WO1998035554A2 (no) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6524832B1 (en) | 1994-02-04 | 2003-02-25 | Arch Development Corporation | DNA damaging agents in combination with tyrosine kinase inhibitors |
CZ15498A3 (cs) | 1995-07-17 | 1998-07-15 | Board Of Regents, The University Of Texas System | Konstrukce pro expresi pl6 a její aplikace při léčení rakoviny |
US7163925B1 (en) | 1995-07-17 | 2007-01-16 | Board Of Regents, The University Of Texas System | p16 expression constructs and their application in cancer therapy |
US7732129B1 (en) | 1998-12-01 | 2010-06-08 | Crucell Holland B.V. | Method for the production and purification of adenoviral vectors |
KR100503701B1 (ko) | 1996-11-20 | 2005-07-26 | 인트로겐 테라페티스, 인코퍼레이티드 | 아데노바이러스 벡터를 생산하고 정제하는 개선된 방법 |
US6096757A (en) | 1998-12-21 | 2000-08-01 | Schering Corporation | Method for treating proliferative diseases |
CA2315693C (en) * | 1997-12-22 | 2010-11-30 | Schering Corporation | Combination of benzocycloheptapyridine compounds and antineoplastic drugs for treating proliferative diseases |
CA2325561A1 (en) * | 1998-04-22 | 1999-10-28 | Inex Pharmaceuticals Corporation | Combination therapy using nucleic acids and conventional drugs |
US6689600B1 (en) | 1998-11-16 | 2004-02-10 | Introgen Therapeutics, Inc. | Formulation of adenovirus for gene therapy |
WO2000056351A2 (en) * | 1999-03-19 | 2000-09-28 | Schering Corporation | Combination use of gemcitabine and tumor suppressor gene therapy in the treatment of neoplasms |
US6316462B1 (en) | 1999-04-09 | 2001-11-13 | Schering Corporation | Methods of inducing cancer cell death and tumor regression |
US6911200B2 (en) | 2000-03-24 | 2005-06-28 | Cell Genesys, Inc. | Methods of treating neoplasia with combination of target-cell specific adenovirus, chemotherapy and radiation |
US7048920B2 (en) | 2000-03-24 | 2006-05-23 | Cell Genesys, Inc. | Recombinant oncolytic adenovirus for human melanoma |
JP4564714B2 (ja) * | 2000-11-27 | 2010-10-20 | ミナーヴァ・バイオテクノロジーズ・コーポレーション | 診断用腫瘍マーカー、腫瘍形成の阻害のための薬物スクリーニング、並びにがん治療用の組成物及び方法 |
EP1340498A1 (en) * | 2002-03-01 | 2003-09-03 | Schering Aktiengesellschaft | Use of epothilones in the treatment of brain diseases associated with proliferative processes |
US7364727B2 (en) | 2002-07-22 | 2008-04-29 | Cell Genesys, Inc. | Metastatic colon cancer specific promoter and uses thereof |
CA2548220A1 (en) | 2003-12-01 | 2005-09-09 | Introgen Therapeutics, Inc. | Use of mda-7 to inhibit infection by pathogenic organisms |
EP1709973A1 (en) * | 2003-12-24 | 2006-10-11 | Locomogene, Inc. | Method of suppressing cancer |
JPWO2005061007A1 (ja) * | 2003-12-24 | 2007-07-12 | 学校法人 聖マリアンナ医科大学 | 癌の抑制方法 |
KR20070104339A (ko) | 2004-11-03 | 2007-10-25 | 인트로겐 테라페티스, 인코퍼레이티드 | 아데노바이러스 벡터의 생산과 정제를 위한 신규한 방법 |
JP6895890B2 (ja) | 2015-02-10 | 2021-06-30 | ミネルバ バイオテクノロジーズ コーポレーション | ヒト化抗muc1* 抗体 |
CN108030931A (zh) * | 2017-03-07 | 2018-05-15 | 大连民族大学 | 一种药物脂质体/p53基因复合物的应用 |
CN109200295A (zh) * | 2018-10-08 | 2019-01-15 | 蚌埠医学院 | 一种用于治疗卵巢癌的药物组合物及其制备方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5747469A (en) * | 1991-03-06 | 1998-05-05 | Board Of Regents, The University Of Texas System | Methods and compositions comprising DNA damaging agents and p53 |
WO1995010514A1 (en) * | 1993-10-15 | 1995-04-20 | Schering Corporation | Tricyclic sulfonamide compounds useful for inhibition of g-protein function and for treatment of proliferative diseases |
PL185597B1 (pl) * | 1995-12-22 | 2003-06-30 | Schering Corp | Tricykliczne amidy, środek farmaceutyczny i ich zastosowania |
-
1998
- 1998-02-17 BR BR9807418-0A patent/BR9807418A/pt not_active Application Discontinuation
- 1998-02-17 AU AU64380/98A patent/AU737621B2/en not_active Ceased
- 1998-02-17 KR KR1020057021095A patent/KR100688409B1/ko not_active IP Right Cessation
- 1998-02-17 PL PL98335334A patent/PL193767B1/pl not_active IP Right Cessation
- 1998-02-17 HU HU0004326A patent/HUP0004326A3/hu unknown
- 1998-02-17 DE DE69837754T patent/DE69837754T2/de not_active Expired - Fee Related
- 1998-02-17 CA CA002282683A patent/CA2282683A1/en not_active Abandoned
- 1998-02-17 CN CNB988042541A patent/CN1248731C/zh not_active Expired - Fee Related
- 1998-02-17 ES ES98910038T patent/ES2287974T3/es not_active Expired - Lifetime
- 1998-02-17 EP EP98910038A patent/EP0969720B1/en not_active Expired - Lifetime
- 1998-02-17 JP JP53603398A patent/JP2001511815A/ja not_active Ceased
- 1998-02-17 KR KR1019997007475A patent/KR100620939B1/ko not_active IP Right Cessation
- 1998-02-17 IL IL13144798A patent/IL131447A0/xx unknown
- 1998-02-17 CZ CZ0293399A patent/CZ298488B6/cs not_active IP Right Cessation
- 1998-02-17 SK SK1122-99A patent/SK285969B6/sk not_active IP Right Cessation
- 1998-02-17 WO PCT/US1998/003514 patent/WO1998035554A2/en active IP Right Grant
- 1998-02-17 AT AT98910038T patent/ATE361668T1/de not_active IP Right Cessation
- 1998-02-17 NZ NZ337283A patent/NZ337283A/en unknown
-
1999
- 1999-08-17 NO NO993943A patent/NO993943L/no not_active Application Discontinuation
-
2000
- 2000-07-12 HK HK00104319A patent/HK1026579A1/xx not_active IP Right Cessation
-
2008
- 2008-11-30 IL IL195605A patent/IL195605A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP0969720A4 (en) | 2004-05-12 |
BR9807418A (pt) | 2002-01-22 |
SK112299A3 (en) | 2000-12-11 |
IL195605A0 (en) | 2011-08-01 |
CN1248731C (zh) | 2006-04-05 |
NO993943L (no) | 1999-10-15 |
SK285969B6 (sk) | 2007-12-06 |
DE69837754D1 (de) | 2007-06-21 |
EP0969720B1 (en) | 2007-05-09 |
WO1998035554A3 (en) | 1998-11-26 |
HK1026579A1 (en) | 2000-12-22 |
DE69837754T2 (de) | 2008-02-07 |
CN1252689A (zh) | 2000-05-10 |
ES2287974T3 (es) | 2007-12-16 |
PL193767B1 (pl) | 2007-03-30 |
AU737621B2 (en) | 2001-08-23 |
JP2001511815A (ja) | 2001-08-14 |
KR100688409B1 (ko) | 2007-03-02 |
PL335334A1 (en) | 2000-04-25 |
HUP0004326A3 (en) | 2003-07-28 |
KR100620939B1 (ko) | 2006-09-06 |
NZ337283A (en) | 2001-02-23 |
IL131447A0 (en) | 2001-01-28 |
HUP0004326A2 (hu) | 2001-02-28 |
CZ298488B6 (cs) | 2007-10-17 |
WO1998035554A2 (en) | 1998-08-20 |
CA2282683A1 (en) | 1998-08-20 |
KR20050113287A (ko) | 2005-12-01 |
EP0969720A2 (en) | 2000-01-12 |
CZ293399A3 (cs) | 2000-03-15 |
AU6438098A (en) | 1998-09-08 |
KR20000071185A (ko) | 2000-11-25 |
ATE361668T1 (de) | 2007-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL195605A0 (en) | Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms | |
PT1157041E (pt) | Anticorpos para terapia e diagnostico de cancro | |
EP1004022A4 (en) | METHODS AND COMPOSITIONS FOR OVERCOMING RESISTANCE TO BIOLOGICAL THERAPY AND CHEMOTHERAPY | |
IL137164A0 (en) | Enzyme catalyzed therapeutic agents | |
TR199902053T2 (xx) | Prostat kanserinin immunoterapisine y�nelik bile�ikler ve bunlar�n kullan�lmas�na matuf metodlar. | |
DE69837529D1 (de) | Proteinmarker für lungenkrebs und deren verwendung | |
TR200103756T2 (tr) | Hümanize anti-ErbB2 antikorları ve anti-ErbB2 antikorlarıyla tedavi. | |
CY1109367T1 (el) | Συνθεσεις και μεθοδοι για ενισχυση της παροχης θεραπευτικων παραγοντων σε κυτταρα | |
DE60041592D1 (de) | Testverfahren für verbindungen die frühzeitige tra | |
ATE255632T1 (de) | Immortalisierung bzw. desimmortalisierung von zellen | |
IL128872A0 (en) | TNF-beta-like protein for treating prostate cancer and related nucleic acid molecules pharmaceutical compositions and methods | |
DK1082423T3 (da) | Cyclin E2-gener og -proteiner | |
AU6249098A (en) | Method of treating cancer using alkylglycerols in conjunction with chemotherapy | |
ATE285247T1 (de) | Krebstherapie mit lymphotoxin | |
HUP9900011A2 (hu) | A GAX protein alkalmazása rák kezelésére | |
DE69735676D1 (de) | Proteinmarker für ösophaguskrebs | |
BR0012301A (pt) | Inibidores de crescimento de células epiteliais | |
WO2000056351A3 (en) | Combination use of gemcitabine and tumor suppressor gene therapy in the treatment of neoplasms | |
CO5080825A1 (es) | Sistema de terapia con genes suicidas para el tratamiento de tumores cerebrales | |
DE60023695D1 (de) | Tumorsuppressormoleküle und nutzungsverfahren |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |